Feature Article

Immunisation: it’s not just for kids



  1. Menzies R, Leask J, Royle J, MacIntyre CR. Vaccine myopia: adult vaccination also needs attention. Med J Aust 2017; 206: 238-239.
  2. Mak DB, Regan AK, Joyce S, Gibbs R, Effler PV. Antenatal care provider’s advice is the key determinant of influenza vaccination uptake in pregnant women. Aust N Z J Obstet Gynaecol 2015; 55: 131-137.
  3. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunisation. Am J Med 2008; 121(7 Suppl 2): S28-S35.
  4. Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook 10th ed (2017 update). Canberra: Australian Government Department of Health; 2017. Available online at: (accessed May 2017).
  5. National Centre for Immunisation Research and Surveillance (NCIRS). Immunisation recommendations for adults in Australia. Sydney: NCIRS; 2015. Available online at: (accessed May 2017).
  6. Australian Government Department of Health, Immunise Australia Program. National Immunisation Program Schedule. Canberra: Commonwealth of Australia; November 2016. Available online at: (accessed May 2017).
  7. Australian Institute of Health and Welfare (AIHW). Australian Burden of Disease Study: fatal burden of disease 2010. Australian Burden of Disease Study series no. 1. Cat. no. BOD 1. Canberra: AIHW; 2015.
  8. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2: 659-666.
  9. Maggi S. Vaccination and healthy ageing. Expert Rev Vaccines 2010; 9(3 Suppl): 3-6.
  10. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013; 31: 618-625.
  11. Australian Institute of Health and Welfare (AIHW). 2009 Adult Vaccination Survey: summary results. Cat. no. PHE 135. Canberra: AIHW; 2011.
  12. Hull BP, Hendry AJ, Dey A, Beard FH, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2014. Commun Dis Intell 2017; 41: E68-E90.
  13. Australian Government Department of Health. Newspoll Omnibus Survey. Flu vaccinations. Summary report. Newspoll Omnibus Ref 140604; 2014. Available online at:$File/summ-report-flu-vaccinations-survey2014.pdf (accessed May 2017).
  14. MacIntyre CR, Menzies R, Kpozehouen E, et al. Equity in disease prevention: vaccines for the older adults – a national workshop, Australia 2014. Vaccine 2016; 34: 5463-5469.
  15. Schmid P, Rauber D, Betsch C, Lidolt G, Denker M-L. Barriers of influenza vaccination intention and behaviour – a systematic review of influenza vaccine hesitancy, 2005 – 2016. PLoS One 2017; 12(1): e0170550.
  16. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32: 1481-1486.
  17. Angell SY, Cetron MS. Health disparities among travellers visiting friends and relatives abroad. Ann Intern Med 2005; 142: 67-72.
  18. Centers for Disease Control and Prevention (CDC). Immigrants returning home to visit friends and relatives (VFRs). Atlanta: CDC; 2015. Available online at: (accessed May 2017).
  19. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-2284.
  20. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384: 1521-1528.
  21. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359: 1555-1564.
  22. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12 :36-44.
  23. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; (2): CD004876.
  24. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults – a randomized controlled trial. JAMA 2000; 284: 1655-1663.
  25. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
  26. Pebody R, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Eurosurveillance 2013; 18: pii=20389.
  27. Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372: 1114-1125.
  28. Pennington K, Enhanced Invasive Pneumococcal Disease Surveillance Working Group; for the Communicable Diseases Network Australia. Invasive pneumococcal disease surveillance, 1 October to 31 December 2016. Canberra: Australian Government Department of Health; 2017. Available online at:$File/IPD-Quarterly-Oct-Dec2016.pdf (accessed May 2017).
  29. Aratchige PE, McIntyre PB, Quinn HE, Gilbert GL. Recent increases in mumps incidence in Australia: the ‘forgotten’ age group in the 1998 Australian Measles Control Campaign. Med J Aust 2008; 189: 434-437.
  30. Dey A, Knox S, Wang H, Beard FH, McIntyre PB. Summary of national surveillance data on vaccine preventable diseases in Australia, 2008-2011. Commun Dis Intell Q Rep 2016; 40 Suppl: S1-70.
  31. National Notifiable Diseases Surveillance System (NNDSS). Annual Report Working Group. Australia’s notifiable disease status, 2014: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2016; 40: E48-E145.
  32. Chan J, Dey A, Wang H, Martin N, Beard F. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012. Commun Dis Intell Q Rep 2015; 39: E19-E26.
  33. Department of Health, Government of Western Australia. Notifiable Infectious Disease Reports – Mumps notifications in Western Australia. Perth: Public Health Division, WA Department of Health; 2017. Available online at: (accessed May 2017).
  34. Australian Government Department of Health. Second National Hepatitis B Strategy 2014-2017. Canberra: Commonwealth of Australia; 2014. Available online at:$File/Hep-B-Strategy2014-v3.pdf (accessed May 2017).
  35. Hunt JM, Lumley J. Top End rural and remote Indigenous women: an Australian population group vulnerable to rubella. Commun Dis Intell 2004; 28: 499-503.
  36. Therapeutic Goods Administration. Database of Adverse Event Notifications (DAEN). Canberra: Commonwealth of Australia; 2017. Available online at: (accessed May 2017).
  37. Dey A, Wang H, Quinn H, Hill R, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2014. Commun Dis Intell 2016; 40: E377-E390.




Dr Deng is the Immunisation Fellow at the National Centre for Immunisation Research & Surveillance (NCIRS), Westmead; and a General Paediatric Advanced Trainee at The Children’s Hospital at Westmead, Sydney. Mr MacDougall is the Regional Infection Prevention and Control Specialist at Public Health Ontario, Toronto, Ontario, Canada. Associate Professor Macartney is the Deputy Director of the National Centre for Immunisation Research & Surveillance (NCIRS), Westmead; Staff Specialist in Infectious Disease and Microbiology at The Children’s Hospital at Westmead; and Associate Professor in the Discipline of Paediatrics and Child Health at the University of Sydney, Sydney, NSW.